Digoxigenin-tagged anti-GFAP and multiple labelling of human glia, vessels and beta-amyloid

Neuroreport. 1994 Jan 31;5(5):573-6. doi: 10.1097/00001756-199401000-00010.

Abstract

Cytochemical procedures for the combined demonstration of astroglia, microglia, blood vessels and beta-amyloid in the human brain were developed. These multiple label experiments include the first adaptation of the digoxigenin-antidigoxigenin technique to immunocytochemistry by using digoxigenylated antibodies directed against the glial fibrillary acidic protein and its visualization in astrocytes with an antidigoxigenin-peroxidase conjugate and diaminobenzidine as chromogen. Furthermore, the specific labelling of microglial cells was performed with the novel enhanced polymer one-step staining technique, non-interfering with conventional detection systems. The demonstration of spatial relationships between glial and vascular components in normal tissue and their alterations, e.g. in Alzheimer's disease, might provide insights into the time course and localization of pathological events.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease / metabolism
  • Alzheimer Disease / pathology*
  • Amyloid beta-Peptides / analysis*
  • Antibodies, Monoclonal / immunology*
  • Astrocytes / chemistry*
  • Astrocytes / ultrastructure
  • Biomarkers
  • Brain / blood supply
  • Brain / pathology*
  • Brain Chemistry*
  • Digoxigenin
  • Glial Fibrillary Acidic Protein / analysis*
  • Humans
  • Immunoenzyme Techniques*
  • Microglia / chemistry*
  • Microglia / ultrastructure
  • Nerve Tissue Proteins / analysis*
  • Temporal Lobe / chemistry
  • Temporal Lobe / ultrastructure

Substances

  • Amyloid beta-Peptides
  • Antibodies, Monoclonal
  • Biomarkers
  • Glial Fibrillary Acidic Protein
  • Nerve Tissue Proteins
  • Digoxigenin